Generation 4 is well advancing!
Movmedix office hosted last July, 25th a visit from Prof. Cerulli, Dr. Tei and Mr. Tiribuzi from I.R.T.A.L Institute, Italy, who is leading the LARS generation 4 development project.
Valuable insights on LARS new generation 4!
Our innovative pipelines
We are thrilled to announce that Movmedix office hosted last July, 25th a visit from Prof. Cerulli, Dr. Tei and Mr. Tiribuzi from I.R.T.A.L Institute, Italy. This was an excellent opportunity for us to exchange valuable insights into our LARS Generation 4, currently under clinical trial led by Prof. Cerulli. 4th generation LARS ligaments are made from a biocompatible and bioactive material: this combination results in an implant that is very well tolerated by the body, still faithfully reproducing the structure and flexibility of a natural ligament. Our team warmly welcomed our distinguished experts and made the most of this meeting! We warmly thank them for this visit, which marks a key milestone in the development of future LARS™ ligaments and illustrates our mission “To offer innovative solutions based on cutting-edge technologies to reduce hospitalization and rehabilitation time, the risk of morbidity and infection, and pain”. Stay tuned for updates and advancements on Generation 4 ligaments.
About Movmedix
Driven by our vision to restore infinite mobility to patients suffering from soft tissue injuries, Movmedix continues to evolve toward becoming a global leader in sports medicine. With more than three decades of expertise, we have been at the forefront of the artificial ligament field — pioneering free-fibre technology and designing implants tailored to specific clinical indications.
Building on the strong legacy of our LARS® (Ligament Advanced Reinforcement System) product range, we remain committed to developing innovative and disruptive solutions that address the evolving needs of surgeons and improve patient outcomes worldwide.
